Puma Biotechnology (PBYI) News Today → The AI Bottleneck No One is Talking About (From The Bull Report) (Ad) Free PBYI Stock Alerts $4.66 -0.34 (-6.80%) (As of 03/18/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlinePuma Biotechnology (NASDAQ:PBYI) Share Price Passes Above 200-Day Moving Average of $4.07americanbankingnews.com - March 12 at 4:22 AMPuma Biotechnology (NASDAQ:PBYI) Upgraded at StockNews.comamericanbankingnews.com - March 12 at 2:34 AMBuy Rating on Puma Biotechnology Amid Financial Challenges and Drug Advancement Prospectsmarkets.businessinsider.com - March 2 at 8:12 AMPuma Biotechnology, Inc. (NASDAQ:PBYI) Shares Could Be 47% Below Their Intrinsic Value Estimatefinance.yahoo.com - March 2 at 8:12 AMPuma Biotechnology, Inc. (PBYI) Q4 2023 Earnings Call Transcriptseekingalpha.com - March 2 at 1:51 AMPuma Biotechnology (NASDAQ:PBYI) PT Lowered to $7.00 at HC Wainwrightmarketbeat.com - March 1 at 3:39 PMPuma Biotechnology Reports Fourth Quarter and Full Year 2023 Financial Resultsbusinesswire.com - February 29 at 4:05 PMPuma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)finance.yahoo.com - February 27 at 11:20 PMPuma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)businesswire.com - February 27 at 6:30 PMPuma Biotechnology to Participate in a Panel Discussion at TD Cowen’s 44th Annual Health Care Conferencefinance.yahoo.com - February 22 at 9:35 PMPuma Biotechnology to Participate in a Panel Discussion at TD Cowen's 44th Annual Health Care Conferencebusinesswire.com - February 22 at 4:10 PMFY2025 Earnings Forecast for Puma Biotechnology, Inc. Issued By Zacks Research (NASDAQ:PBYI)marketbeat.com - February 22 at 8:17 AMPuma Biotech (PBYI) Is Up 23.01% in One Week: What You Should Knowmsn.com - February 21 at 2:33 PMPuma Biotechnology, Inc. (NASDAQ:PBYI) to Post FY2024 Earnings of $0.42 Per Share, Zacks Research Forecastsmarketbeat.com - February 21 at 7:59 AMPuma Biotechnology to Host Conference Call to Discuss Fourth Quarter and Full Year 2023 Financial Resultsfinance.yahoo.com - February 15 at 7:16 PMPuma Biotechnology to Host Conference Call to Discuss Fourth Quarter and Full Year 2023 Financial Resultsbusinesswire.com - February 15 at 4:10 PMPuma Biotechnology (NASDAQ:PBYI) Stock Rating Lowered by StockNews.commarketbeat.com - February 14 at 1:26 AMPuma Biotechnology Inc.wsj.com - February 13 at 8:49 AMPuma Biotechnology Announces Initiation of ALISCA-Lung1 Phase II Trial of Alisertib in Small Cell Lung Cancerfinance.yahoo.com - February 13 at 8:49 AMPBYI vs. AMGN: Which Stock Should Value Investors Buy Now?msn.com - February 9 at 1:11 PMAssenagon Asset Management S.A. Sells 154,179 Shares of Puma Biotechnology, Inc. (NASDAQ:PBYI)marketbeat.com - February 9 at 4:47 AMImmunome (IMNM) to Acquire Desmoid Tumor Candidate, Stock Upfinance.yahoo.com - February 7 at 1:49 PM3 small-cap biotechs with potential breakthroughs in 2024 (PBYI)marketbeat.com - February 6 at 10:15 AMNovo Nordisk (NVO) to Acquire 3 Catalent Sites for $11Bfinance.yahoo.com - February 5 at 2:47 PMPuma Biotechnology Inc PBYImorningstar.com - January 30 at 11:43 PMLSV Asset Management Cuts Holdings in Puma Biotechnology, Inc. (NASDAQ:PBYI)marketbeat.com - January 30 at 5:32 AMMirum (MIRM) Banks on Livmarli Sales Despite Recent Setbackfinance.yahoo.com - January 23 at 5:06 PMLisata (LSTA) Stock Up More Than 35% in 3 Months: Here's Whyfinance.yahoo.com - January 23 at 5:06 PMPuma Biotech (PBYI) Is Attractively Priced Despite Fast-paced Momentumfinance.yahoo.com - January 22 at 1:11 PMVor Bio (VOR) Up on Positive Update From AML Cell Therapy Studyfinance.yahoo.com - January 19 at 10:54 AMPuma Biotech (PBYI) Stock Jumps 10.0%: Will It Continue to Soar?msn.com - January 17 at 6:15 AMIGM Bio (IGMS) Stock Rallies 142% in 3 Months: Here's Whyfinance.yahoo.com - January 16 at 12:38 PMAdicet (ACET) Stock Rallies 130% in a Month: Here's Whyfinance.yahoo.com - January 15 at 3:49 PMPuma Biotechnology to Present at B. Riley Securities 4th Annual Oncology Conferencefinance.yahoo.com - January 11 at 6:24 PMSarepta (SRPT) Rises on Solid Q4 and 2023 Preliminary Resultsfinance.yahoo.com - January 9 at 1:04 PMPuma Biotechnology Inc CEO Alan Auerbach Sells 41,396 Sharesgurufocus.com - January 6 at 10:00 AMAlvin F. Wong Sells 7,733 Shares of Puma Biotechnology, Inc. (NASDAQ:PBYI) Stockmarketbeat.com - January 5 at 9:44 PMPuma Biotechnology (NASDAQ:PBYI) Downgraded by StockNews.commarketbeat.com - January 4 at 1:24 AMPuma Biotech (PBYI) Shows Fast-paced Momentum But Is Still a Bargain Stockfinance.yahoo.com - January 3 at 1:33 PMPuma Biotechnology (NASDAQ:PBYI) Stock Rating Upgraded by StockNews.commarketbeat.com - December 27 at 10:13 PMPuma Biotechnology Stock (NASDAQ:PBYI) Dividends: History, Yield and Datesbenzinga.com - December 25 at 10:15 AMargenx (ARGX) Tanks on Top-Line Data From Pemphigus Studyfinance.yahoo.com - December 21 at 12:08 PMBlueprint (BPMC) Gets EC Nod for Ayvakit Expanded Use, Stock Upfinance.yahoo.com - December 13 at 3:01 PMKymera (KYMR) Rises as Dosing Begins in AD Study on KT-474finance.yahoo.com - December 8 at 12:38 PMSyros (SYRS) Rises on Upbeat Initial Study Data on Tamibarotenefinance.yahoo.com - December 7 at 2:42 PMHere Is Why Bargain Hunters Would Love Fast-paced Mover Puma Biotech (PBYI)msn.com - December 1 at 2:11 PMAbbVie (ABBV) Lymphoma Drug Gets FDA Breakthrough Therapy Tagfinance.yahoo.com - November 28 at 2:12 PMPBYI Puma Biotechnology, Inc.seekingalpha.com - November 24 at 8:35 AMHere's Why You May Invest in Puma Biotechnology (PBYI) Stockfinance.yahoo.com - November 20 at 1:57 PMEdward White’s Buy Rating for Puma Biotechnology: Strong Financial Performance and Promising Market Potential for Nerlynxmarkets.businessinsider.com - November 4 at 7:56 AM Get Puma Biotechnology News Delivered to You Automatically Sign up to receive the latest news and ratings for PBYI and its competitors with MarketBeat's FREE daily newsletter. Email Address They said crypto was dead. It went up 100X. (Ad)Bitcoin’s haters are out again. Despite the price doubling in the last six months alone… That hasn’t stopped the experts from piling on. Warren Buffett’s right-hand man Charlie Munger called crypto investors “idiots” in one of his last interviews. JPMorgan CEO Jamie Dimon, recently called Bitcoin a “pet rock” and “a hyped-up fraud.” But when it comes to cryptos, these are exactly the people you shouldn’t listen to. They’ve predicted crypto’s demise for years. There are five coins you must take a look at right away. PBYI Media Mentions By Week PBYI Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PBYI News Sentiment▼0.980.63▲Average Medical News Sentiment PBYI News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PBYI Articles This Week▼21▲PBYI Articles Average Week Get Puma Biotechnology News Delivered to You Automatically Sign up to receive the latest news and ratings for PBYI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Rigel Pharmaceuticals News Today Omeros News Today Pyxis Oncology News Today Incannex Healthcare News Today Conduit Pharmaceuticals News Today Greenwich LifeSciences News Today Annexon News Today 2seventy bio News Today 23andMe News Today Verastem News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PBYI) was last updated on 3/19/2024 by MarketBeat.com Staff From Our PartnersCentral Bank Gold Heist In ProgressColonial Metals8,788% Return Predicted For THIS Crypto (already up 40% in 6 months)Paradigm PressAltcoin FRENZY Alert…Crypto 101 MediaThe AI Bottleneck No One is Talking AboutThe Bull ReportThe world’s greatest investmentPorter & CompanyMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceSHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Puma Biotechnology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.